Philip Morris International opened a $1.2 billion manufacturing campus in Aurora, Colorado, dedicated to producing ZYN nicotine pouches, doubling the project's original $600 million estimate. The 780,000-square-foot facility, built on 148 acres, combines production, packaging, warehousing, and distribution, and is expected to employ about 500 people once fully staffed. The opening follows a June 30 FDA authorization making ZYN the first nicotine pouch allowed to market itself as lower risk than cigarettes. Meanwhile, rival British American Tobacco reported a 65.9% increase in Modern Oral revenue in the first half of 2026, driven by Velo Plus and Grizzly Modern Oral, and plans a national US rollout of its higher-strength Velo Max in the second half of the year.
Philip Morris International IncOpens $1.2B ZYN plant, doubling investment, with FDA authorization boosting market position.
British American Tobacco PLCReports 65.9% revenue growth in Modern Oral, driven by Velo Plus and Grizzly, with national rollout planned.
Bill Com Holdings Inc